{"id":"W4414420388","doi":"10.1002/hem3.70224","title":"The impact of reduced dosing frequency of elranatamab on patient‐reported outcomes in patients with relapsed or refractory multiple myeloma: Results from MagnetisMM‐3","year":2025,"lang":"en","type":"letter","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Cancer Foundation","funders":"Pfizer","keywords":"Dosing; Refractory (planetary science); Incidence (geometry); Multiple myeloma; Clinical trial; Quality of life (healthcare)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002949042,0.0005427258,0.001311625,0.000203145,0.0002891932,0.0009274693,0.0004597689,0.000532972,0.00224246],"category_scores_gemma":[0.003048997,0.0001332377,0.002989025,0.0005008185,0.0002855819,0.0007211837,0.0004652969,0.00201873,0.0003785823],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007051599,"about_ca_system_score_gemma":0.000659731,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001163797,"about_ca_topic_score_gemma":0.002066041,"domain_scores_codex":[0.9989811,0.0004990015,0.0001084783,0.0001210315,0.000183515,0.000106904],"domain_scores_gemma":[0.9980919,0.0005132716,0.0007710423,0.000131554,0.0001594207,0.0003328134],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4145176,0.0129772,0.1301925,0.002372238,0.01131128,0.0001092744,0.0003795778,0.003130214,0.005037137,0.000327041,0.006986512,0.4126595],"study_design_scores_gemma":[0.08760019,0.254158,0.6278234,0.0005969547,0.01180405,0.0003746008,0.0002929879,0.003650493,0.002435525,0.0007285586,0.01040284,0.0001324564],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9745592,0.01927604,0.0002892437,0.001142529,0.0001930418,0.0002728559,0.001890795,0.00004493705,0.002331362],"genre_scores_gemma":[0.9911466,0.003924925,0.0004664208,0.001101875,0.0003233829,0.0003613913,0.002110992,0.00001346192,0.000550925],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002949042,"threshold_uncertainty_score":0.01559621,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0211115781070035,"score_gpt":0.2916552370376649,"score_spread":0.2705436589306615,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}